Scientists testing HIV cure report 'remarkable' progress after patient
Landmark HIV vaccine trial
Towards an HIV Cure
Breaking Down the Latest in HIV Cure Research: What do new data mean
COMMENTS
This is how the world finally ends the HIV/AIDS pandemic
Research Highlight 23 OCT 24. HIV: how close are we to a vaccine — or a cure? News Explainer 02 SEP 24. Stunning trial shows twice-yearly shots can prevent HIV infection. Research Highlight 02 ...
Researchers a step closer to a cure for HIV
Researchers a step closer to a cure for HIV. A new study shows virus-like particle can effectively 'shock and kill' latent HIV reservoir in those living with chronic HIV. By 2030, the World Health ...
A seventh case of HIV cure reported at AIDS 2024
A seventh case of HIV cure reported at AIDS 2024. During the 25th International AIDS Conference (AIDS 2024), being held in Munich, Germany, a new case of long HIV remission was reported and fuels optimism for an eventual HIV cure. In 2007, Timothy Brown, the so-called first Berlin patient, was the first person to be considered cured of HIV.
Twice-yearly shot proves successful at preventing HIV infection among
Lenacapavir is already approved by the US Food and Drug Administration for the treatment of HIV infection in adults, in combination with other HIV antiretroviral medicines, and it's estimated to ...
Seventh patient 'cured' of HIV: why scientists are excited
To many scientists, these cases suggested that CCR5 was the best target for an HIV cure. The latest case — presented at the 25th International AIDS Conference in Munich, Germany, this week ...
HIV: how close are we to a vaccine
In the absence of vaccines, pre-exposure prophylaxis, or PrEP, has been key to stemming the spread of HIV. Until recently, PrEP existed only in the form of oral medicines that must be taken daily ...
HIV Treatment Research and Key Takeaways: Dr. Dieffenbach's Final
More than 3,600 HIV and infectious disease researchers from 73 countries gathered in Denver and virtually from March 3-6 this year for CROI, an annual scientific meeting on the latest research that can help accelerate global progress in the response to HIV and other infectious diseases, including STIs and viral hepatitis.
New findings from Emory study offer potential breakthrough in HIV cure
Emory's Gavegnano Group demonstrates ability to remove key barrier to an HIV cure. The results of a novel study presented by Emory researchers during the International AIDS Society (IAS) Conference in Brisbane, Australia, have revealed exciting findings in the pursuit of an HIV cure. The study, led by Monica Reece, a PhD candidate in Emory ...
Clinical trial begins using CAR T cells to potentially cure HIV
The search for an HIV cure. Currently, there are approximately 38 million people living with HIV around the world and over half of them receive antiretroviral therapy. Despite the progress made in treatment, in 2021 there were an estimated 1.5 million new cases and 650,000 people died from AIDS-related illnesses worldwide, according to UNAIDS.
New findings offer potential breakthrough in HIV cure research
New findings offer potential breakthrough in HIV cure research. ScienceDaily . Retrieved November 10, 2024 from www.sciencedaily.com / releases / 2023 / 07 / 230726113046.htm
Proof-of-concept study to find functional cure for HIV
This proof-of-concept study signals what technologies could come for the 1.2 million people in the United States and 39 million worldwide (as of 2022) with HIV who depend on medications to keep ...
OHSU research offers clues for potential widespread HIV cure in people
New research from Oregon Health & Science University is helping explain why at least five people have become HIV-free after receiving a stem cell transplant. The study's insights may bring scientists closer to developing what they hope will become a widespread cure for the virus that causes AIDS, which has infected about 38 million people ...
New Trial Highlights Incremental Progress Towards a Cure for HIV-1
If ART is discontinued, HIV will awaken from its dormant state, begin to replicate, and cause acquired immunodeficiency syndrome (AIDS). To create a cure, researchers have been attempting to drive HIV out of latency and target it for destruction. A new clinical trial led by Cynthia Gay, MD, MPH, associate professor of infectious diseases, David ...
Scientific Leadership Spotlighted as Gilead Presents Research Data
Additional HIV treatment research findings include an oral presentation of a pooled analysis of efficacy and safety outcomes from a Phase 1b study (NCT04811040) evaluating the treatment responses ...
Prevention, treatment and cure of HIV infection
Treatment can block new infection events but does not eradicate long-lived populations of cells harbouring integrated replication-competent proviruses (the 'reservoir'). ... HIV cure research ...
Scientific Leadership Spotlighted as Gilead Presents Research Data
Gilead researchers have developed 12 HIV medications, including the first single-tablet regimen to treat HIV, the first antiretroviral for pre-exposure prophylaxis (PrEP) to help reduce new HIV infections, and the first long-acting injectable HIV treatment medication administered twice-yearly.
Scientists say they can cut HIV out of cells
Even with effective treatment, some go into a resting, or latent, state - so they still contain the DNA, or genetic material, of HIV, even if not actively producing new virus. Most people with HIV ...
New HIV drug can only offer hope of ending AIDS if all have access
GENEVA, 10 July 2024— UNAIDS has welcomed the release of Gilead Sciences' trial results on the injectable long-acting HIV medicine Lenacapavir for HIV prevention. The result "provides hope of accelerating efforts to end AIDS", UNAIDS says, "but only if Gilead ensures that all people who need it can have access to this game-changing medicine."
Research Toward HIV Cure
Investing in research to find a cure for HIV is focused on two broad aims: sustained viral remission and, in the longer term, viral eradication. Viral latency and sanctuaries. Latent HIV reservoirs—small amounts of HIV that persist in people taking ART—present a significant challenge to finding a cure for HIV. Latent reservoirs remain in ...
Gilead Presents New Data From HIV Cure Research Program and
These latest findings represent an ongoing multi-pronged approach in Gilead's HIV cure research program. The data were presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2023 in Seattle.
Research priorities for an HIV cure: International AIDS ...
An effective and scalable cure strategy is a top priority for the HIV research field; this Review discusses recent advances, knowledge gaps, and priority research areas for the next 5 years.
Study links historical redlining to delays in HIV treatment
A new study from Tulane University finds that historical race-based lending practices are still impacting health today, linking these discriminatory policies to delays in effective HIV treatment ...
Working to End the HIV Epidemic Through Innovation, Equity
From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million people with HIV (PWH) and 37,981 new cases of HIV in the United States ...
Where are we in the search for an HIV cure?
A resource of HIV cure trials maintained by the Treatment Action Group, a New York-based advocacy organisation, lists hundreds of clinical trials currently under way that are trying these different approaches or combinations of approaches. ... Douek was speaking on an IAS webinar on HIV cure research. Another promising approach is to start ...
Pharmacists' Research Contributions in the Fight against HIV/AIDs
Pharmacists have made many contributions to HIV/AIDs research and are still showing their significance as members of the healthcare team through innovative clinical trials. Pharmacists are showing advances in several healthcare settings including inpatient, outpatient, and community pharmacies.
IMAGES
COMMENTS
Research Highlight 23 OCT 24. HIV: how close are we to a vaccine — or a cure? News Explainer 02 SEP 24. Stunning trial shows twice-yearly shots can prevent HIV infection. Research Highlight 02 ...
Researchers a step closer to a cure for HIV. A new study shows virus-like particle can effectively 'shock and kill' latent HIV reservoir in those living with chronic HIV. By 2030, the World Health ...
A seventh case of HIV cure reported at AIDS 2024. During the 25th International AIDS Conference (AIDS 2024), being held in Munich, Germany, a new case of long HIV remission was reported and fuels optimism for an eventual HIV cure. In 2007, Timothy Brown, the so-called first Berlin patient, was the first person to be considered cured of HIV.
Lenacapavir is already approved by the US Food and Drug Administration for the treatment of HIV infection in adults, in combination with other HIV antiretroviral medicines, and it's estimated to ...
To many scientists, these cases suggested that CCR5 was the best target for an HIV cure. The latest case — presented at the 25th International AIDS Conference in Munich, Germany, this week ...
In the absence of vaccines, pre-exposure prophylaxis, or PrEP, has been key to stemming the spread of HIV. Until recently, PrEP existed only in the form of oral medicines that must be taken daily ...
More than 3,600 HIV and infectious disease researchers from 73 countries gathered in Denver and virtually from March 3-6 this year for CROI, an annual scientific meeting on the latest research that can help accelerate global progress in the response to HIV and other infectious diseases, including STIs and viral hepatitis.
Emory's Gavegnano Group demonstrates ability to remove key barrier to an HIV cure. The results of a novel study presented by Emory researchers during the International AIDS Society (IAS) Conference in Brisbane, Australia, have revealed exciting findings in the pursuit of an HIV cure. The study, led by Monica Reece, a PhD candidate in Emory ...
The search for an HIV cure. Currently, there are approximately 38 million people living with HIV around the world and over half of them receive antiretroviral therapy. Despite the progress made in treatment, in 2021 there were an estimated 1.5 million new cases and 650,000 people died from AIDS-related illnesses worldwide, according to UNAIDS.
New findings offer potential breakthrough in HIV cure research. ScienceDaily . Retrieved November 10, 2024 from www.sciencedaily.com / releases / 2023 / 07 / 230726113046.htm
This proof-of-concept study signals what technologies could come for the 1.2 million people in the United States and 39 million worldwide (as of 2022) with HIV who depend on medications to keep ...
New research from Oregon Health & Science University is helping explain why at least five people have become HIV-free after receiving a stem cell transplant. The study's insights may bring scientists closer to developing what they hope will become a widespread cure for the virus that causes AIDS, which has infected about 38 million people ...
If ART is discontinued, HIV will awaken from its dormant state, begin to replicate, and cause acquired immunodeficiency syndrome (AIDS). To create a cure, researchers have been attempting to drive HIV out of latency and target it for destruction. A new clinical trial led by Cynthia Gay, MD, MPH, associate professor of infectious diseases, David ...
Additional HIV treatment research findings include an oral presentation of a pooled analysis of efficacy and safety outcomes from a Phase 1b study (NCT04811040) evaluating the treatment responses ...
Treatment can block new infection events but does not eradicate long-lived populations of cells harbouring integrated replication-competent proviruses (the 'reservoir'). ... HIV cure research ...
Gilead researchers have developed 12 HIV medications, including the first single-tablet regimen to treat HIV, the first antiretroviral for pre-exposure prophylaxis (PrEP) to help reduce new HIV infections, and the first long-acting injectable HIV treatment medication administered twice-yearly.
Even with effective treatment, some go into a resting, or latent, state - so they still contain the DNA, or genetic material, of HIV, even if not actively producing new virus. Most people with HIV ...
GENEVA, 10 July 2024— UNAIDS has welcomed the release of Gilead Sciences' trial results on the injectable long-acting HIV medicine Lenacapavir for HIV prevention. The result "provides hope of accelerating efforts to end AIDS", UNAIDS says, "but only if Gilead ensures that all people who need it can have access to this game-changing medicine."
Investing in research to find a cure for HIV is focused on two broad aims: sustained viral remission and, in the longer term, viral eradication. Viral latency and sanctuaries. Latent HIV reservoirs—small amounts of HIV that persist in people taking ART—present a significant challenge to finding a cure for HIV. Latent reservoirs remain in ...
These latest findings represent an ongoing multi-pronged approach in Gilead's HIV cure research program. The data were presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2023 in Seattle.
An effective and scalable cure strategy is a top priority for the HIV research field; this Review discusses recent advances, knowledge gaps, and priority research areas for the next 5 years.
A new study from Tulane University finds that historical race-based lending practices are still impacting health today, linking these discriminatory policies to delays in effective HIV treatment ...
From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million people with HIV (PWH) and 37,981 new cases of HIV in the United States ...
A resource of HIV cure trials maintained by the Treatment Action Group, a New York-based advocacy organisation, lists hundreds of clinical trials currently under way that are trying these different approaches or combinations of approaches. ... Douek was speaking on an IAS webinar on HIV cure research. Another promising approach is to start ...
Pharmacists have made many contributions to HIV/AIDs research and are still showing their significance as members of the healthcare team through innovative clinical trials. Pharmacists are showing advances in several healthcare settings including inpatient, outpatient, and community pharmacies.